Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Boeckers, Madeleine; Paul, Norbert W.; Efferth, Thomas
Organophosphate ester tri-o-cresyl phosphate interacts with estrogen receptor alpha in MCF-7 breast cancer cells promoting cancer growthTOXICOLOGY AND APPLIED PHARMACOLOGY. Bd. 395. 2020
Finn, Richard S.; Boer, Katalin; Bondarenko, Igor et al.
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2-advanced breast cancer (PALOMA-1, TRIO-18)BREAST CANCER RESEARCH AND TREATMENT. Bd. 183. H. 2. 2020 S. 419-428
Noordhoek, Iris; Blok, Erik J.; Kranenbarg, Elma Meershoek-Klein et al.
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL TrialsJOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 28. 2020 S. 3273-+
Zahnreich, S.; Gebrekidan, S.; Brieger, J. et al.
Oxygen deprivation modulates EGFR expression and activity in squamous cell carcinomas of the head and neckSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. SUPPL 1. 2020 S. S14-S14
Levy, Antonin; Wagner, Anna D.; Chargari, Cyrus et al.
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary positionEUROPEAN JOURNAL OF CANCER. Bd. 135. 2020 S. 103-112
Frappart, Pierre-Olivier; Hofmann, Thomas G.
Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized MedicineCANCERS. Bd. 12. H. 10. 2020
Galle, Peter R.; Finn, Richard S.; Qin, Shukui et al.
Patient-reported outcomes (PROs) from the Phase III IMbrave150 trial of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Locati, Laura D.; Galbiati, Donata; Calareso, Giuseppina et al.
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of lifeCANCER. 2020
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi et al.
Pattern of progression in advanced HCC treated with ramucirumab/placebo: Results from two randomized phase III trials (REACH/REACH-2)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi et al.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumabLIVER INTERNATIONAL. 2020